Home > Media > Press releases > Archive 2002
Ferring Logo
  • Home
  • About Us
  • Therapeutic Areas
  • Research & Development
  • Working at Ferring
  • Business Development
  • Media
media1a.jpg

Press releases

Archive 2007

Archive 2006

Archive 2005

Archive 2004

Archive 2003

Archive 2002

Corporate Press Materials

Media Contacts

Search

Contact us

Global Locator

Friday, November 08, 2002

5-ASAs/mesalazine May Lower Colorectal Cancer Risk in Inflammatory Bowel Disease (IBD)

|More|
Wednesday, October 30, 2002

Ferring and Johnson & Johnson Join in a Research Collaboration

|More|
Wednesday, October 02, 2002

Ferring appoints new Board member

|More|
Tuesday, October 01, 2002

Ferring Pharmaceuticals and Beth Israel Deaconess Medical Center Announce Drug Discovery Collaboration Agreement

|More|
Tuesday, October 01, 2002

Ferring Appoints New Vice-President of Global Marketing

|More|
Thursday, May 16, 2002

Taking the Needle Out of the Injection

|More|
Monday, May 13, 2002

Ferring Appoints New Board Member

|More|
Monday, May 06, 2002

FDA APPROVES BRAVELLE™ (urofollitropin for injection, purified)

|More|
Thursday, March 21, 2002

Building for the 21st Century

|More|
Friday, February 22, 2002

First international consultation on nocturia sheds light on neglected disease area

|More|
  Next>

Print

Mail

Sitemap
Global Locator
Legal Disclaimer
© Ferring 2008
© Copyright Label Ferring. All world rights reserved.
 |  Event Calendar |  Global Locator |  Search |  FAQS |  Sitemap |  Legal Disclaimer